|
Department Circular 2021-0396 |
September 01, 2021 |
Reiteration of Department Circular No. 2021-0323 on price cap for COVID-19 Rapid Antigen Testing |
|
Department Circular 2021-0374 |
August 26, 2021 |
Price Cap for COVID-19 Reverse Transcriptions-Polymerase Reaction (RT-PCR) Testing |
|
Department Circular 2021-0375 |
August 24, 2021 |
Reiteration of functions of Infectious Control Committees in health facilities and modification of staffing patterns and further clarification of the shortening of quarantine for the healthcare workers |
|
Department Memorandum 2021-0287 |
June 18, 2021 |
Guidelines for the Management and administration of COVID-19 mRNA Vaccine (Nucleoside Modified) Moderna COVID-19 Vaccine |
|
Joint Memorandum Circular 2021-0001 |
June 03, 2021 |
Procedures on the Procurement and Distribution of COVID-19 Vaccines for Private Entities |
|
Department Memorandum 2021-0259 |
May 31, 2021 |
Implementing Guidelines for Priority Groups A4, A5 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines |
|
Department Memorandum 2021-0223 |
May 06, 2021 |
Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event |
|
Department Memorandum 2021-0197 |
April 19, 2021 |
Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event |
|
Department Memorandum 2021-0175 |
April 08, 2021 |
Further Clarification on the National Deployment and Vaccination Plan for COVID-19 Vaccines and Additional Guidelines for Sinovac Implementation |
|
Department Circular 2021-0122 |
April 05, 2021 |
Reiteration of Prevention, Detection, Isolation, Treatment, and Reintegration (PDITR) Strategies for COVID-19 in Light of the Implementation of Enhance Community Quarantine in NCR Plus Bubble |
|
Department Circular 2021-0118 |
March 31, 2021 |
Continuity of Operations of Private COVID-19 Testing Laboratories during the Observance of the Holy Week |
|
Department Memorandum 2021-0161 |
March 31, 2021 |
Interim Guidelines for the Conduct of Saliva-Based RT-PCR Testing for the Detection of SARS Cov-2 |
